Startups
Ionetix: Offering leading radiopharmaceuticals for advanced diagnostics & therapeutics in health systems, hospitals, and nuclear medicine.
Overview
Location
United States, Michigan, Lansing
Total raised
$30M
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 7, 2024 | Ionetix Closes Financing | Ionetix Corporation, a Lansing, Mich.-based cyclotron technology innovator and isotope manufacturer for diagnostic and therapeutic applications, received a financing of undisclosed amount. Backers were Eli Lilly and Company, as well as exis... |
| Jun 7, 2024 | IONETIX Produces First Batch of Actinium-225 | LANSING, Mich., June 7, 2024 /PRNewswire/ -- IONETIX, a leading cyclotron technology innovator, isotope producer, and radiopharmaceutical manufacturer, announced today the successful production of Actinium-225 ("Ac-225") at its is... |
| Mar 16, 2021 | IONETIX Announces Targeted Alpha Therapy Manufacturing Center | LANSING, Mich., March 16, 2021 /PRNewswire/ -- IONETIX, a leading cyclotron technology and isotope manufacturing company, has acquired a 10,300 sq. ft. facility in Lansing, MI for its new Targeted Alpha Radionuclide Manufacturing Center. Th... |
| Mar 16, 2021 | IONETIX Announces Targeted Alpha Therapy Manufacturing Center |
Reviews 0
FAQ about Ionetix
How much funding has Ionetix raised?
Ionetix has raised $30M in total across 1 funding round.
What has the press written about Ionetix?
Parsers VC has collected 5 articles mentioning Ionetix, among them “Ionetix Closes Financing” (Aug 7, 2024) and “IONETIX Produces First Batch of Actinium-225” (Jun 7, 2024).
Is Ionetix still active?
Yes, Ionetix is active; its latest activity on Parsers VC dates from Apr 24, 2026.